These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27123811)

  • 1. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
    Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
    Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
    Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.
    Yin S; Xia C; Wang Y; Wan D; Rao J; Tang X; Wei J; Wang X; Li M; Zhang Z; Liu J; He Q
    J Control Release; 2018 Oct; 288():148-160. PubMed ID: 30099017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced glioma therapy by synergistic inhibition of autophagy and tyrosine kinase activity.
    Wang X; Qiu Y; Yu Q; Li H; Chen X; Li M; Long Y; Liu Y; Lu L; Tang J; Zhang Z; He Q
    Int J Pharm; 2018 Jan; 536(1):1-10. PubMed ID: 28887220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine loaded hollow apoferritin nanocages for cancer drug repurposing and autophagy inhibition.
    Fang X; Zeng J; Li Y; Yu H; Wu Z; Qi X
    Eur J Pharm Biopharm; 2024 Oct; 203():114473. PubMed ID: 39186959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antitumour strategy using bidirectional autophagic vesicles accumulation via initiative induction and the terminal restraint of autophagic flux.
    Wang Y; Tai X; Zhang L; Liu Y; Gao H; Chen J; Shi K; Zhang Q; Zhang Z; He Q
    J Control Release; 2015 Feb; 199():17-28. PubMed ID: 25499918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-Loaded Doxorubicin Liposomes Based on Ion-Pairing Technology with High Drug Loading and pH-Responsive Property.
    Xu H; Zhang L; Li L; Liu Y; Chao Y; Liu X; Jin Z; Chen Y; Tang X; He H; Kan Q; Cai C
    AAPS PharmSciTech; 2017 Aug; 18(6):2120-2130. PubMed ID: 28028795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two methods for tumour-targeting peptide modification of liposomes.
    Huang SQ; Zhang HM; Zhang YC; Wang LY; Zhang ZR; Zhang L
    Acta Pharmacol Sin; 2023 Apr; 44(4):832-840. PubMed ID: 36271156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
    Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
    Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
    Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
    Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy.
    Zamani P; Navashenaq JG; Teymouri M; Karimi M; Mashreghi M; Jaafari MR
    Life Sci; 2020 Jul; 252():117646. PubMed ID: 32272178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
    Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
    J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
    Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
    J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells.
    Pedrini I; Gazzano E; Chegaev K; Rolando B; Marengo A; Kopecka J; Fruttero R; Ghigo D; Arpicco S; Riganti C
    Mol Pharm; 2014 Sep; 11(9):3068-79. PubMed ID: 25057799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion.
    Mauthe M; Orhon I; Rocchi C; Zhou X; Luhr M; Hijlkema KJ; Coppes RP; Engedal N; Mari M; Reggiori F
    Autophagy; 2018; 14(8):1435-1455. PubMed ID: 29940786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.
    Shi NQ; Li Y; Zhang Y; Li ZQ; Qi XR
    Int J Nanomedicine; 2018; 13():5537-5559. PubMed ID: 30271146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.